Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Unaudited Financial Results For The Quarter Ended June 30, 2023

 In compliance with Regulation 30 and 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform that the Board of Directors of the Company at its meeting held today i.e., Friday, August 11, 2023 inter alia, considered and approved Unaudited Financial results of the Company for the quarter ended June 30, 2023 along with Limited Review Report issued thereon.
11-08-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Company will host an Earnings Conference Call for Investors/Analysts on Monday, August 14, 2023 at 4:30 p.m. (IST), during which officials of the Company will discuss the business background/prospects and financial performance of the Company and take questions. The details of the Earnings Conference Call are mentioned in the Call Invite enclosed herewith.
08-08-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Intimation for Consideration And Approval Of, Inter Alia, Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2023

 GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 ,inter alia, to consider and approve 1)Unaudited Financial Results of the Company for the Quarter ended 30.06.2023 along with the Limited Review Report issued by the Statutory Auditors' thereon. 2)Gufic Biosciences Limited Employees Stock Options Plan 2023, subject to approval of shareholders of the Company at the ensuing Annual General Meeting and such other approvals as may be required. Further in continuation to our disclosure on the Closure of Trading Window dated 29.06.2023, the trading window in respect of dealing in the Equity Shares of the Company for all the Designated Persons of the Company along with their immediate relatives, shall continue to remain close until 48 hours post declaration of the said financial results.
04-08-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, please find enclosed herewith certificate received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company for the quarter ended June 30, 2023.
07-07-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Closure of Trading Window

 This is to inform that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and the Company''s Code of Conduct framed under the said provisions, the Trading Window for dealing in securities of the Company shall remain closed for all the Designated Persons and their immediate relatives from July 01, 2023 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ended June 30, 2023. The date of meeting of the Board of Directors to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2023 will be intimated in due course.
29-06-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Clarification On Increase In Volume Of Security

 With reference to your email bearing Ref. No. L/SURV/ONL/PV/NP/ 2023-2024/157 dated June 19, 2023 seeking clarification on significant increase in the volume of security across Exchanges in the recent past, please find attached herewith our response for the same.
19-06-2023

Gufic Biosciences share price rises over 4% to hit 52-week high; here's why

 Stock Market News- Gufic Biosciences shares rise over 4% to a new 52-week high after receiving approval from China's NMPA for its product Prilocaine, aiding commercialization in China.
19-06-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith a press release being issued by the Company on the captioned subject, the contents of which is self-explanatory. The same is submitted for public dissemination and for your record.
16-06-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed herewith the copies of Newspaper advertisement published today i.e. June 7, 2023 in Business Standard (All Edition in English language) and Mumbai Lakshwadeep (Mumbai Edition in Marathi language) in accordance with Rule 6 of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended from time to time ('IEPF Rules'), inviting attention of concerned shareholders to submit their claims in respect of unclaimed dividends of the Company for last seven consecutive years failing which their shares would be transferred to IEPF Authority in accordance with Section 124(6) of the Companies Act, 2013 and rules made thereunder.
07-06-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 This is in continuation to our communication dated May 30, 2023 on Earnings Conference Call and pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, written transcript of the said call held on May 30, 2023 at 4:30 p.m., has been uploaded on the Company's website which can be accessed through the link: http://gufic.com/Notice/WrittenTranscript_3005223.pdf
02-06-2023
Next Page
Close

Let's Open Free Demat Account